All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @dietcoach4u on TikTok · 112s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @dietcoach4u's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Let's talk about what a GOP-1 plateau is.
  2. 0:04My name's Dustin.
  3. 0:05I help over 4,000 GOP-1 journey, and this is how I explain GOP-1 plateau.
  4. 0:09So what a plateau is, your metabolism is no longer exceeding the amount of calories you
  5. 0:14consume.
  6. 0:15As you can see from this chart, over time your metabolism slows, and eventually it equals
  7. 0:20the amount of calories you're consuming, which causes a plateau.
  8. 0:23This is mainly because your metabolism is crashing because of loss muscle mass.
  9. 0:27According to the studies roughly 40% of weight loss is muscle loss, muscle is the biggest
  10. 0:31driver from metabolism, and also is why a specific phase happens, and if a big butt happens,
  11. 0:37you're losing so much muscle, your skin has nothing to hold on to, but at the same time
  12. 0:41crash your metabolism slows down weight loss and more.
  13. 0:45And so over time, as you can see from the chart, your metabolism slows, and eventually
  14. 0:49it equals to the amount of calories you consume.
  15. 0:51Once you get there, you have two options.
  16. 0:52One is to continue starving yourself, which will cause the same issue over time.
  17. 0:57You lose more muscle, you lose more metabolism, and eventually you may not have any more calories
  18. 1:01to cut.
  19. 1:02The answer would be to increase your metabolism.
  20. 1:06To do this, you have three ways.
  21. 1:07Number one, increase protein that forces your body to burn more calories.
  22. 1:11Number two is to resistance train.
  23. 1:13However, only resistance training if you're eating enough protein, I tell my clients
  24. 1:17do not work out unless you're eating 80 grams of protein or more.
  25. 1:21And three, vitamins, minerals, and nutrients.
  26. 1:25That's important for thyroid function, testosterone levels.
  27. 1:28You don't want to look like a long sports aneger, but you do want to have optimal testosterone
  28. 1:31levels, cortisol reduction to help with fat burning and weight loss and blood sugar and
  29. 1:36insulin regulation.
  30. 1:37If you do those things, you're going to increase your metabolism.
  31. 1:40Hopefully you do it from the very beginning, so it's never an issue.
  32. 1:42Plus, you're going to get a lean tone physique by doing these things, so it's not just weight
  33. 1:46loss, it's fat loss, it gets scarps and all those good things.
  34. 1:50Need help?
  35. 1:51Let me know.

GLP-1 plateaus: what the science says vs. TikTok fixes

Dustin Holston the Biohacker

TikTok creator

9.6K viewsWatch on TikTok

Quick answer

GLP-1 receptor agonists including semaglutide and tirzepatide produce weight loss through appetite suppression and slowed gastric emptying, but lean mass loss during treatment is a documented clinical concern that may contribute to metabolic adaptation over time. Resistance training and adequate dietary protein are the most evidence-supported interventions for preserving lean mass in this context, though specific numerical thresholds vary by individual patient profile. Patients experiencing weight-loss plateaus on GLP-1 therapy should consult their prescribing clinician before making significant changes to diet, exercise, or supplementation.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 plateaus: what the science says vs. TikTok fixes, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

GLP-1 plateaus: what the science says vs. TikTok fixes is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GLP-1 plateaus: what the science says vs. TikTok fixes" from Dustin Holston the Biohacker. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists including semaglutide and tirzepatide produce weight loss through appetite suppression and slowed gastric emptying, but lean mass loss during treatment is a documented clinical concern that may contribute to metabolic adaptation over time.

The reason this review is not generic is the source wording and the canonical claim label "glp1 what is a glp 1 plateau and how to fix it diet weightloss." In this clip, the useful excerpt is: "Let's talk about what a GOP-1 plateau is." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Resistance training combined with semaglutide significantly improves lean mass retention compared to medication alone, according to Wallner et al.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GLP-1 receptor agonists including semaglutide and tirzepatide produce weight loss through appetite suppression and slowed gastric emptying, but lean mass loss during treatment is a documented clinical concern that may contribute to metabolic adaptation over time.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GLP-1 receptor agonists including semaglutide and tirzepatide produce weight loss through appetite suppression and slowed gastric emptying, but lean mass loss during treatment is a documented clinical concern that may contribute to metabolic adaptation over time. Resistance training and adequate dietary protein are the most evidence-supported interventions for preserving lean mass in this context, though specific numerical thresholds vary by individual patient profile. Patients experiencing weight-loss plateaus on GLP-1 therapy should consult their prescribing clinician before making significant changes to diet, exercise, or supplementation.
  • Lean mass loss on GLP-1 medications is real: estimates from clinical trials suggest 25-39% of total weight lost may come from lean mass without resistance training or adequate protein (Wilding et al., 2021, NEJM).
  • Resistance training combined with semaglutide significantly improves lean mass retention compared to medication alone, according to Wallner et al. (2024, Obesity).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Lean mass loss on GLP-1 medications is real: estimates from clinical trials suggest 25-39% of total weight lost may come from lean mass without resistance training or adequate protein (Wilding et al., 2021, NEJM).
  • Resistance training combined with semaglutide significantly improves lean mass retention compared to medication alone, according to Wallner et al. (2024, Obesity).
  • The thermic effect of protein is approximately 20-30%, meaning higher protein intake does modestly increase daily calorie expenditure, making it a legitimate metabolic lever.
  • Protein targets during active weight loss are better individualized by body weight (1.2-1.6 g/kg/day per Leidy et al., 2015, AJCN) than set as a flat 80-gram daily floor for everyone.
  • No supplement stack has been shown in a controlled trial to reverse a GLP-1 plateau. Supplementation is relevant only when a specific deficiency is confirmed through testing.
  • Weight-loss plateaus on GLP-1s are influenced by more than muscle loss alone. Hormonal adaptation, dose titration, and changes in physical activity all play a role and require clinical evaluation.
  • Continuing to cut calories indefinitely during a plateau is genuinely counterproductive; the creator's advice to avoid that approach is consistent with current clinical thinking.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @dietcoach4u actually say?

Dustin, who claims to guide over 4,000 people on GLP-1 medications, argues that weight-loss plateaus happen because your metabolism slows as you lose muscle. He says "roughly 40% of weight loss is muscle loss," which crashes your metabolism until calories burned equals calories consumed. His fix: eat more protein (at least 80 grams daily before any resistance training), do resistance training, and supplement with vitamins and minerals to support thyroid function, testosterone, cortisol, and blood sugar regulation. He also references a phenomenon he calls a "big butt" phase, where skin loses support as muscle disappears.

The core argument is that GLP-1 plateau is primarily a metabolic slowdown driven by muscle loss, and that you can reverse it through protein intake, resistance training, and micronutrient support. That framework is not entirely wrong, but several specific claims deserve serious scrutiny.

Does the science back this up?

Partially, yes. The general relationship between muscle loss, metabolic adaptation, and weight plateaus is real and documented. But the specific numbers and some of the supplement claims are either exaggerated or unsupported.

GLP-1 receptor agonists like semaglutide do produce meaningful fat loss, but they also carry lean mass loss risk. A 2023 trial published in NEJM (Wilding et al.) found that semaglutide users lost significant body weight, but body composition data from related trials suggest that roughly 25-39% of total weight lost can come from lean mass, depending on whether resistance training and adequate protein intake are present. The "40% muscle loss" figure Dustin cites is in the ballpark of some estimates but presented without nuance or a specific citation.

On protein and resistance training: the evidence here is solid. Cava et al. (2017, Advances in Nutrition) confirmed that higher protein intake preserves lean mass during caloric restriction, and resistance training compounds that effect. The 80-gram threshold Dustin sets is a rough minimum, not a precise clinical target, but it is not a dangerous recommendation for most adults.

What did they get wrong (or right)?

Let's give credit where it is due. The basic mechanism Dustin describes, that muscle loss slows metabolism and contributes to plateaus, is supported by research. Recommending protein and resistance training together is genuinely good advice, and the point that you should not keep cutting calories indefinitely is correct.

What he gets wrong, or at least oversimplifies:

  • The "40% muscle loss" claim is presented as settled science. It is not. Lean mass loss on GLP-1s varies considerably based on dose, diet, and exercise. Presenting it as a fixed number is misleading.
  • His claim that vitamins, minerals, and nutrients drive fat burning, testosterone, cortisol reduction, and blood sugar regulation is vague to the point of being unverifiable. There is no evidence that a general supplement stack meaningfully reverses a GLP-1 plateau. Specific deficiencies matter; broad supplementation claims do not hold up.
  • He does not mention that metabolic adaptation on GLP-1s is also driven by hormonal and neural mechanisms beyond just muscle loss. The drugs themselves alter appetite signaling, gastric emptying, and energy expenditure in ways that are not purely about lean mass.
  • The "big butt" phase claim is anecdotal and not referenced in any peer-reviewed literature. It may describe a real cosmetic observation, but framing it as a physiological phenomenon without evidence is sloppy.

What should you actually know?

If you are on a GLP-1 medication and hitting a plateau, here is what the evidence actually supports.

Weight loss plateaus on GLP-1s are common and expected. A 2022 analysis by Davies et al. in Diabetes Care noted that plateau timing varies by individual, dose titration, and adherence. Simply waiting out a plateau or cutting more calories is rarely the right move.

Protein intake genuinely matters. Research from Leidy et al. (2015, American Journal of Clinical Nutrition) supports targeting 1.2-1.6 grams of protein per kilogram of body weight during active weight loss to preserve lean mass. Eighty grams per day is a reasonable floor for many people but is not a universal prescription.

Resistance training is the most evidence-backed tool for preserving muscle during GLP-1-assisted weight loss. A 2024 study by Wallner et al. in Obesity found that combining semaglutide with structured resistance training significantly improved lean mass retention compared to drug alone.

Supplement claims should be treated skeptically. If you have a confirmed deficiency in vitamin D, magnesium, or another micronutrient, correcting it matters. But no supplement stack has been shown in controlled trials to meaningfully reverse a GLP-1 plateau on its own.

If you are concerned about your progress on a GLP-1 medication, talk to a licensed clinician. Dose titration, dietary adjustments, and exercise programming should be individualized, not sourced from TikTok.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dustin Holston the Biohacker · TikTok creator

9.6K views on this video

What is a GLP-1 plateau and how to fix it. #diet #weightloss

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about lean mass loss on glp-1 medications?

Lean mass loss on GLP-1 medications is real: estimates from clinical trials suggest 25-39% of total weight lost may come from lean mass without resistance training or adequate protein (Wilding et al., 2021, NEJM).

What does the video say about resistance training combined with semaglutide significantly improves lean mass retention?

Resistance training combined with semaglutide significantly improves lean mass retention compared to medication alone, according to Wallner et al. (2024, Obesity).

What does the video say about the thermic effect of protein?

The thermic effect of protein is approximately 20-30%, meaning higher protein intake does modestly increase daily calorie expenditure, making it a legitimate metabolic lever.

What does the video say about protein targets during active weight loss?

Protein targets during active weight loss are better individualized by body weight (1.2-1.6 g/kg/day per Leidy et al., 2015, AJCN) than set as a flat 80-gram daily floor for everyone.

What does the video say about no supplement stack has been shown in a controlled trial?

No supplement stack has been shown in a controlled trial to reverse a GLP-1 plateau. Supplementation is relevant only when a specific deficiency is confirmed through testing.

What does the video say about weight-loss plateaus on glp-1s?

Weight-loss plateaus on GLP-1s are influenced by more than muscle loss alone. Hormonal adaptation, dose titration, and changes in physical activity all play a role and require clinical evaluation.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dustin Holston the Biohacker, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.